Apollo Hospitals Reports Strong FY26 Performance, Proposes Business Demerger

Consolidated Revenue: ₹25,228.5 crore | Consolidated PAT: ₹2,002.7 crore

Reader Takeaway: Strong financial growth and strategic restructuring for future value creation.

What just happened

Apollo Hospitals Enterprise Ltd announced its financial results for the fiscal year ended March 31, 2026. The company reported a consolidated revenue of ₹25,228.5 crore, a 16% increase from ₹21,794 crore in the previous year. Consolidated profit after tax (PAT) surged by 33% to ₹2,002.7 crore, up from ₹1,505.1 crore in FY 2024-25. The Board also approved a scheme to demerge its pharmacy distribution, digital platform (Apollo 24|7), and telehealth businesses into a new entity, Apollo Healthtech Limited.

Why this matters

This performance highlights the company's strong operational execution and growth trajectory. The proposed demerger is a significant strategic move aimed at unlocking value by creating a more focused structure for its hospital services and the rapidly growing digital health segment. This could lead to better market recognition and valuation for each business vertical.

The backstory

Apollo Hospitals has been steadily expanding its hospital network and digital offerings. The company has been investing in its integrated healthcare model, combining physical infrastructure with digital solutions. This financial year's results reflect the maturing of these investments and successful market penetration.

What changes now

The demerger, once approved by regulators and shareholders, will create Apollo Healthtech Limited, housing the pharmacy and digital ventures. Apollo Hospitals will likely continue to focus on its core hospital operations. Additionally, the company proposed combining its maternity and fertility care businesses with Cloudnine to create a larger specialized platform.

Risks to watch

Investors will need to closely monitor the progress and timelines for regulatory approvals for the demerger and business combination. Execution of the aggressive expansion plans, including adding 1,000 new beds in FY 2026-27 and 8,000 by FY 2030-31, also presents execution risks.

Peer comparison

While specific peer financial data for FY26 is pending, Apollo Hospitals' growth in revenue and PAT is generally in line with the robust performance seen across the Indian healthcare sector, driven by increasing healthcare expenditure and demand for quality services.

Context metrics (time-bound)

Consolidated revenue for FY 2025-26 was ₹25,228.5 crore, a 16% year-on-year increase. Consolidated PAT for the same period was ₹2,002.7 crore, up 33% year-on-year. A dividend of ₹20 per share was declared.

What to track next

Investors should watch for updates on the demerger process, including timelines and shareholder approvals. The company's ability to execute its bed expansion strategy and the performance of its demerged entities will be key factors going forward.